Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection

BMC Medicine

Volumn 2, Issue , 2004, Pages

  Andrieu, Jean Marie ^a   Lu, Wei ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BIOLOGICAL MARKER; CALCIUM; CD4 ANTIGEN; COTRIMOXAZOLE; GLUCOCORTICOID; POTASSIUM; PREDNISOLONE 3 SULFOBENZOATE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VITAMIN D; ZIDOVUDINE; PREDNISOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT DISORDER; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FACE DISORDER; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNE SYSTEM; IMMUNOLOGY; LONG TERM CARE; LYMPHOCYTE COUNT; MALE; PILOT STUDY; PREDICTION; RETROSPECTIVE STUDY; T LYMPHOCYTE; VIROLOGY; VIRUS LOAD; WEIGHT GAIN; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; TREATMENT REFUSAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; GLUCOCORTICOIDS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; MALE; PILOT PROJECTS; PREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT REFUSAL; VIRAL LOAD;

EID: 4243077569     PISSN: 17417015     EISSN: None     Source Type: Journal    
DOI: 10.1186/1741-7015-2-17     Document Type: Article

References (25)

1. Andrieu JM, Even P, Venet A: AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications. AIDS Res 1986, 2:163-174.
2. Andrieu JM, Even P, Venet A, Tourani JM, Stern M, Lowenstein W, Audroin C, Eme D, Masson D, Sors H: Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol 1988, 47:181-198.
3. Levy R, Jais JP, Tourani JM, Even P, Andrieu JM: Long-term follow-up of HIV positive asymptomatic patients having received cyclosporin A. Adv Exp Med Biol 1995, 374:229-234.
4. Lu W, Salerno-Goncalves R, Yuan J, Sylvie D, Han DS, Andrieu JM: Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy. AIDS 1995, 9:35-42.
5. Andrieu JM, Lu W, Levy R: Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis 1995, 171:523-530.
6. Nicoletti I, Migliorati G, Pagliaci MC, Grignani F, Riccardi CJ: A rapid simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991, 139:271-279.
7. Lu W, Cao L, Ty L, Arlie M, Andrieu JM: Equivalent amplification of intrinsically variable nucleic acid sequences by multipleprimer-induced overlapping amplification assay: applications for universal detection and quantitation. Nat Med 1999, 5:1081-1085.
8. Wallis RS, Kalayjian R, Jacobson JM, Fox L, Purdue L, Shikuma CM, Arakaki R, Snyder S, Coombs RW, Bosh RJ, Spritzler J, Chemoff M, Aga E, Myers L, Schock B, Lederman MM: A study of the immunology, virology and safety of Prednisone in HIV-1 infected subjects with CD4 cell counts of 200 to 700 mm-3. J Acquir Immune Defic Syndr 2003, 32:281-286.
9. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976, 84:304-315.
10. Cloyd MW, Chen JJ, Adeqboyega P, Wang L: How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Curr Mol Med 2001, 1:545-550.
11. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
12. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
13. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996, 271:1582-1586.
14. Andrieu JM, Lu W: Viro-immunopathogenesis of HIV disease: implications for therapy. Immunol Today 1995, 16:5-7.
15. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE: CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002, 8:319-323.
16. Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, Longo N, Navarro J, Munoz-Fernandez MA, Sanchez-Mateos P, Corbi AL: DC-SIGN (CD 209) expression is IL-4 dependant and is negatively regulated by IFN, TGF-beta, and antiinflammatory agents. J Immunol 2002, 168:2634-2643.
17. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274:94-96.
18. Salerno-Goncalves R, Lu W, Achour A, Andrieu JM: Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Immunol Lett 1998, 64:71-77.
19. Lu W, Achour A, Arlie M, Cao L, Andrieu JM: Enhanced dendriticcells-driven proliferation and anti-HIV activity of CD8+ T cells by a new phenothiazine derivative aminoperazine. J Immunol 2001, 167:2929-2935.
20. Lu W, Andrieu JM: In vitro HIV eradication by autologous CD8+ T cells expanded with inactivated-virus-pulsed dendritic cells. J Virol 2001, 75:8949-8956.
21. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL: HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000, 192:63-75.
22. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, Forster R, Rowland-Jones S, Sekaly RP, McMichael AJ, Pantaleo G: Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001, 410:106-111.
23. Kostense S, Vandenberghe K, Joling J, Van Baarle D, Nanlohy N, Manting E, Miedema F: Persistent numbers of tetramer(+) CD8(+) T cells, but loss of interferon-gamma(+) HIV-specific T cells during progression to AIDS. Blood 2002, 99:2505-2511.
24. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990, 322:166-172.
25. Rizzardi GP, Harari A, Capiluppi B, Tambussi G, Ellefsen K, Ciuffreda D, Champagne P, Bart PA, Chave JP, Lazzarin A, Pantaleo G: Treatment of primary HIV-1 infection with Cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 2002, 109:681-688.